Yifeng Pharmacy Chain Statistics
Total Valuation
Yifeng Pharmacy Chain has a market cap or net worth of CNY 28.55 billion. The enterprise value is 26.69 billion.
Market Cap | 28.55B |
Enterprise Value | 26.69B |
Important Dates
The last earnings date was Thursday, October 31, 2024.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | Oct 15, 2024 |
Share Statistics
Yifeng Pharmacy Chain has 1.21 billion shares outstanding. The number of shares has increased by 1.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.21B |
Shares Change (YoY) | +1.00% |
Shares Change (QoQ) | +0.58% |
Owned by Insiders (%) | 11.85% |
Owned by Institutions (%) | 19.42% |
Float | 555.39M |
Valuation Ratios
The trailing PE ratio is 18.75 and the forward PE ratio is 17.74. Yifeng Pharmacy Chain's PEG ratio is 1.14.
PE Ratio | 18.75 |
Forward PE | 17.74 |
PS Ratio | 1.19 |
PB Ratio | 2.78 |
P/TBV Ratio | n/a |
P/FCF Ratio | 6.66 |
P/OCF Ratio | n/a |
PEG Ratio | 1.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.04, with an EV/FCF ratio of 6.23.
EV / Earnings | 17.52 |
EV / Sales | 1.12 |
EV / EBITDA | 7.04 |
EV / EBIT | 12.39 |
EV / FCF | 6.23 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.51.
Current Ratio | 1.19 |
Quick Ratio | 0.83 |
Debt / Equity | 0.51 |
Debt / EBITDA | 1.46 |
Debt / FCF | 1.29 |
Interest Coverage | 10.89 |
Financial Efficiency
Return on equity (ROE) is 15.79% and return on invested capital (ROIC) is 8.96%.
Return on Equity (ROE) | 15.79% |
Return on Assets (ROA) | 5.48% |
Return on Capital (ROIC) | 8.96% |
Revenue Per Employee | 603,225 |
Profits Per Employee | 38,417 |
Employee Count | 39,652 |
Asset Turnover | 0.97 |
Inventory Turnover | 3.99 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.09% in the last 52 weeks. The beta is 0.27, so Yifeng Pharmacy Chain's price volatility has been lower than the market average.
Beta (5Y) | 0.27 |
52-Week Price Change | -24.09% |
50-Day Moving Average | 22.86 |
200-Day Moving Average | 28.22 |
Relative Strength Index (RSI) | 44.99 |
Average Volume (20 Days) | 14,928,872 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yifeng Pharmacy Chain had revenue of CNY 23.92 billion and earned 1.52 billion in profits. Earnings per share was 1.26.
Revenue | 23.92B |
Gross Profit | 9.23B |
Operating Income | 2.15B |
Pretax Income | 2.15B |
Net Income | 1.52B |
EBITDA | 2.36B |
EBIT | 2.15B |
Earnings Per Share (EPS) | 1.26 |
Balance Sheet
The company has 8.06 billion in cash and 5.55 billion in debt, giving a net cash position of 2.51 billion or 2.07 per share.
Cash & Cash Equivalents | 8.06B |
Total Debt | 5.55B |
Net Cash | 2.51B |
Net Cash Per Share | 2.07 |
Equity (Book Value) | 10.90B |
Book Value Per Share | 8.46 |
Working Capital | 2.39B |
Cash Flow
In the last 12 months, operating cash flow was 5.08 billion and capital expenditures -796.24 million, giving a free cash flow of 4.29 billion.
Operating Cash Flow | 5.08B |
Capital Expenditures | -796.24M |
Free Cash Flow | 4.29B |
FCF Per Share | 3.54 |
Margins
Gross margin is 38.59%, with operating and profit margins of 9.00% and 6.37%.
Gross Margin | 38.59% |
Operating Margin | 9.00% |
Pretax Margin | 8.99% |
Profit Margin | 6.37% |
EBITDA Margin | 9.87% |
EBIT Margin | 9.00% |
FCF Margin | 17.92% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 2.09%.
Dividend Per Share | 0.50 |
Dividend Yield | 2.09% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 35.04% |
Buyback Yield | -1.00% |
Shareholder Yield | 1.09% |
Earnings Yield | 5.33% |
FCF Yield | 15.02% |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.
Last Split Date | Jun 7, 2024 |
Split Type | Forward |
Split Ratio | 1.2 |
Scores
Yifeng Pharmacy Chain has an Altman Z-Score of 2.83. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.83 |
Piotroski F-Score | n/a |